ArticleDermatology and therapy2025

Long-Term Efficacy and Potential Predictors of Tralokinumab Dose Optimization in Elderly Patients: A Multicentre Study.

Francisco Javier Melgosa Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.